Aksel Siva, EAN 2019 - Unmet needs in the treatment of progressive multiple sclerosis

European editorial board member Aksel Siva (Istanbul University Cerrahpasa School of Medicine, Istanbul, Turkey) considers the major unmet needs in the treatment of progressive multiple sclerosis.
Speaker disclosure: Aksel Siva has received honoraria for educational presentations and consultation fees from Novartis, Sanofi-Genzyme, F. Hoffmann-La Roche, Biogen Idec/Gen Pharma of Turkey, Merck Serono and Teva; received travel and registration coverage for attending several national or international congresses or symposia from Merck Serono, Biogen Idec/Gen Pharma of Turkey, Genzyme and , F. Hoffmann-La Roche.
Filmed at the 5th Congress of the European Academy of Neurology (EAN), Oslo, Norway, June 2019.